Related Experiment Video
Updated: Jul 19, 2026
08:53
A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo
Published on: January 10, 2025
New agents that stimulate erythropoiesis
1Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. hfbunn@rics.bwh.harvard.edu
Blood
|October 13, 2006
Summary
New erythropoiesis-stimulating agents offer improved anemia treatment. Strategies include modifying erythropoietin (Epo), using Epo-mimetic peptides, and activating hypoxia-inducible factor (HIF) pathways for better red blood cell production.
Area of Science:
- Hematology
- Pharmacology
- Biochemistry
Background:
- Recombinant human erythropoietin (rhEpo) effectively treats anemias associated with renal disease and malignancy.
- Concerns regarding rhEpo include cost, parenteral administration, and anti-Epo antibody development.
Purpose of the Study:
- To explore novel strategies for stimulating erythropoiesis beyond traditional rhEpo.
- To identify improved agents for anemia management.
Main Methods:
- Enhancing Epo half-life through N-linked glycosylation, polyethylene glycol conjugation, or multimerization.
- Utilizing Epo-mimetic peptides to activate the Epo receptor pathway.
- Pharmacologically inducing hypoxia-inducible factor (HIF) with oral agents.
Main Results:
- Modified Epo variants demonstrate prolonged circulation and sustained erythropoietic effects.
- Epo-mimetic peptides successfully stimulate red blood cell production.
- HIF activation enhances endogenous Epo and other erythropoiesis-related gene expression.
Conclusions:
- Novel approaches offer promising alternatives for anemia treatment.
- These strategies address limitations of current rhEpo therapies, improving patient outcomes.
More Related Videos
Related Concept Videos
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:24Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...